|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2007-07-10 Purchase(A) |
2007-08-02 6:34 pm | BIOENVISION INC | BIVN | GENZYME CORP Wichita Bio CORP (10% owner) | 8,398,098 | $5.6 | $47,029,349 | 8,398,098 (Direct) |
View |
| 2007-07-10 Purchase(A) |
2007-07-16 2:33 pm |
BIOENVISION INC | BIVN | GENZYME CORP Wichita Bio CORP (10% owner) | 8,613,567 | $5.6 | $48,235,975 | 8,613,567 (Direct) | View |
| 2007-07-10 Purchase | 2007-07-11 8:23 pm |
BIOENVISION INC | BIVN | GENZYME CORP Wichita Bio CORP (10% owner) | 8,706,644 | $5.6 | $48,757,206 | 8,706,644 (Direct) |
View |
| 2006-03-08- -2006-03-09 Sale | 2006-03-13 3:07 pm |
BIOENVISION INC | BIVN | Nelson Thomas Scott (Director) | 90,000 | $7.698 | $692,803 | 161,787 (Direct) |
View |
| 2006-03-06 Sale | 2006-03-07 4:26 pm |
BIOENVISION INC | BIV | WOOD CHRISTOPHER B (Chairman, CEO Director) | 15,000 | $7.951 | $119,271 | 2,239,905 (Direct) | View |
| 2006-03-06 Sale | 2006-03-07 4:25 pm |
BIOENVISION INC | BIV | LUCI DAVID P (CFO & Gen. Counsel) | 135,000 | $7.96 | $1,074,668 | 169,054 (Direct) | View |
| 2006-03-06 Sale | 2006-03-07 4:24 pm |
BIOENVISION INC | BIVN | Griffith Hugh (Chief Operating Officer) | 60,000 | $7.928 | $475,668 | 0 (Direct) | View |
| 2006-02-28 Sale | 2006-03-02 11:39 am | BIOENVISION INC | BIV | LUCI DAVID P (CFO & Gen. Counsel) | 65,000 | $8.572 | $557,160 | 304,054 (Direct) | View |
| 2006-02-28 Sale |
2006-03-01 2:05 pm | BIOENVISION INC | BIVN | Griffith Hugh (Chief Operating Officer) | 65,000 | $8.572 | $557,160 | 60,000 (Direct) | View |
| 2006-02-28 Sale |
2006-03-01 2:03 pm |
BIOENVISION INC | BIVN | Abercrombie Ian (Sales Manager (Europe)) | 50,000 | $8.593 | $429,665 | 0 (Direct) |
View |
| 2005-09-02- -2005-09-12 Sale | 2005-09-14 1:27 pm |
BIOENVISION INC | BIVN | Nelson Thomas Scott (Director) | 80,000 | $8.879 | $710,350 | 251,787 (Direct) |
View |
| 2004-12-22 Sale |
2004-12-23 12:35 pm |
BIOENVISION INC | BIVN | PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC (See Footnotes (2), (3), (4) 10% owner) | 15,342 | $8.546 | $131,114 | 375,044 (Indirect) |
View |
| 2004-12-22 Sale |
2004-12-23 12:30 pm |
BIOENVISION INC | BIVN | PEARL FRANK H PERSEUSPUR LLC (See Footnotes (3) and (4) 10% owner) | 21,745 | $8.61 | $187,229 | 375,044 (Indirect) | View |
| 2004-12-22 Sale | 2004-12-23 12:27 pm |
BIOENVISION INC | BIVN | PEARL FRANK H PERSEUSPUR LLC (See Footnotes (3) and (4) 10% owner) | 7,102 | $8.35 | $59,300 | 396,789 (Indirect) |
View |
| 2004-12-22 Sale |
2004-12-23 12:14 pm |
BIOENVISION INC | BIVN | SOROS FUND MANAGEMENT LLC SOROS GEORGE (See Footnotes (3) and (4) 10% owner) | 56,193 | $8.61 | $483,834 | 375,044 (Indirect) | View |
| 2004-12-22 Sale | 2004-12-23 12:09 pm | BIOENVISION INC | BIVN | SOROS FUND MANAGEMENT LLC SOROS GEORGE (See Footnotes (3) and (4) 10% owner) | 18,345 | $8.35 | $153,177 | 431,237 (Indirect) | View |
| 2004-12-21 Sale |
2004-12-23 11:47 am |
BIOENVISION INC | BIVN | PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC (See Footnotes (2), (3), (4) 10% owner) | 41,823 | $8.429 | $352,525 | 390,386 (Indirect) |
View |
| 2004-12-21 Sale | 2004-12-23 11:45 am | BIOENVISION INC | BIVN | PEARL FRANK H PERSEUSPUR LLC (See Footnotes (3) and (4) 10% owner) | 78,633 | $8.429 | $662,795 | 403,891 (Indirect) |
View |
| 2004-12-21 Sale | 2004-12-23 11:41 am | BIOENVISION INC | BIVN | SOROS FUND MANAGEMENT LLC SOROS GEORGE (See Footnotes (3) and (4) 10% owner) | 203,190 | $8.429 | $1,712,682 | 449,582 (Indirect) |
View |
| 2004-05-13 Purchase | 2004-05-17 5:41 pm |
BIOENVISION INC | BIV | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC PEARL FRANK H SOROS GEORGE SOROS FUND MANAGEMENT LLC PERSEUS EC LLC PERSEUSPUR LLC (10% owner) | 375,044 | $6.25 | $2,344,025 | 375,044 (Direct) | View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership | Filing |
| 2007-07-10 Other | 2007-07-12 6:48 pm | BIOENVISION INC | BIVN | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC PERSEUSPUR LLC PEARL FRANK H SOROS FUND MANAGEMENT LLC SOROS GEORGE (10% owner) | 3,375,044 | $5.6 | $18,900,246 | 0 (Direct) |
View |
| 2007-07-10 Equity Swap | 2007-07-12 12:19 pm |
BIOENVISION INC | BIVN | WOOD CHRISTOPHER B (CEO and Chairman Director) | 1,654,031 | $5.6 | $9,262,574 | 0 (Direct) | View |
| 2007-07-10 Equity Swap |
2007-07-12 12:13 pm |
BIOENVISION INC | BIVN | Sterling Robert (VP-Product Development) | 15,225 | $5.6 | $85,260 | 0 (Direct) | View |
| 2007-07-10 Equity Swap | 2007-07-12 12:11 pm | BIOENVISION INC | BIVN | Nelson Thomas Scott (Director) | 79,955 | $5.6 | $447,748 | 0 (Direct) | View |
| 2007-07-10 Equity Swap |
2007-07-12 12:07 pm | BIOENVISION INC | BIVN | LUCI DAVID P (EVP & General Counsel) | 310,154 | $5.6 | $1,736,862 | 0 (Direct) |
View |
| 2007-05-01 Exercise | 2007-06-07 3:29 pm | BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 688,333 | $1.5 | $1,032,500 | 6,807,297 (Direct) |
View |
| 2007-05-02 Exercise |
2007-05-04 5:16 pm |
BIOENVISION INC | BIVN | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC PERSEUSPUR LLC PEARL FRANK H SOROS FUND MANAGEMENT LLC SOROS GEORGE (10% owner) | 3,000,000 | $2 | $6,000,000 | 3,375,044 (Direct) |
View |
| 2006-11-27 Option Award Tax Withholding |
2006-11-28 12:14 pm | BIOENVISION INC | BIVN | LUCI DAVID P (CFO & Gen. Counsel) | 68,900 | $4.94 | $340,366 | 310,154 (Direct) |
View |
| 2006-11-01 Exercise |
2006-11-03 4:20 pm | BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 1,950,707 | $2.038 | $3,974,996 | 69,583 (Direct Indirect) |
View |
| 2006-04-03 Exercise |
2006-04-05 4:33 pm | BIOENVISION INC | BIVN | LUCI DAVID P (CFO & Gen. Counsel) | 110,000 | $0.735 | $80,850 | 279,054 (Direct) |
View |
| 2006-02-27 Exercise | 2006-03-01 2:05 pm |
BIOENVISION INC | BIVN | Griffith Hugh (Chief Operating Officer) | 125,000 | $1.45 | $181,250 | 125,000 (Direct) |
View |
| 2006-02-27 Exercise | 2006-03-01 2:03 pm |
BIOENVISION INC | BIVN | Abercrombie Ian (Sales Manager (Europe)) | 50,000 | $1.29 | $64,500 | 50,000 (Direct) | View |
| 2004-12-13 Other Purchase(A) | 2004-12-16 09:54 am |
BIOENVISION INC | BIVN | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP (10% owner) | 3,000,000 | $0 | $0 | 375,044 (Direct) | View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2007-07-10 Purchase |
2007-08-02 6:34 pm |
N/A N/A | BIOENVISION INC | BIVN | GENZYME CORP Wichita Bio CORP (10% owner) | 2,250,000 | $0 | 2,250,000 (Direct) |
View |
| 2007-07-10 Purchase | 2007-07-16 2:33 pm | N/A N/A | BIOENVISION INC | BIVN | GENZYME CORP Wichita Bio CORP (10% owner) | 2,250,000 | $0 | 2,250,000 (Direct) | View |
| 2007-07-10 Other | 2007-07-12 6:48 pm | N/A N/A |
BIOENVISION INC | BIVN | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC PERSEUSPUR LLC PEARL FRANK H SOROS FUND MANAGEMENT LLC SOROS GEORGE (10% owner) | 2,250,000 | $0 | 0 (Direct) | View |
| 2007-07-10 Purchase | 2007-07-11 8:23 pm |
N/A N/A |
BIOENVISION INC | BIVN | GENZYME CORP Wichita Bio CORP (10% owner) | 2,250,000 | $0 | 2,250,000 (Direct) |
View |
| 2007-05-01 Exercise |
2007-06-07 3:29 pm | N/A 2007-05-08 | BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 688,333 | $1.5 | 0 (Direct) |
View |
| 2007-05-02 Exercise | 2007-05-04 5:16 pm |
2002-05-07 2007-05-07 | BIOENVISION INC | BIVN | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC PERSEUSPUR LLC PEARL FRANK H SOROS FUND MANAGEMENT LLC SOROS GEORGE (10% owner) | 1 | $6e+06 | 0 (Direct) |
View |
| 2007-01-12 Option Award |
2007-01-16 4:21 pm | N/A 2017-01-12 |
BIOENVISION INC | BIVN | WOOD CHRISTOPHER B (Chairman and CEO Director) | 157,500 | $4.67 | 2,552,500 (Direct) |
View |
| 2007-01-12 Option Award | 2007-01-16 4:19 pm |
N/A 2017-01-12 | BIOENVISION INC | BIVN | Nelson Thomas Scott (Director) | 25,000 | $4.67 | 40,000 (Direct) | View |
| 2007-01-12 Option Award | 2007-01-16 4:15 pm | N/A 2017-01-12 |
BIOENVISION INC | BIVN | Griffith Hugh (COO) | 140,000 | $4.67 | 90,000 (Direct) | View |
| 2007-01-12 Option Award |
2007-01-16 4:13 pm |
N/A 2017-01-12 |
BIOENVISION INC | BIVN | Abercrombie Ian (Programme Director (Europe)) | 37,500 | $4.67 | 173,750 (Direct) | View |
| 2007-01-03 Option Award |
2007-01-05 2:43 pm | N/A 2017-01-03 |
BIOENVISION INC | BIVN | Sterling Robert (VP Product Development) | 20,000 | $4.6 | 152,500 (Direct) |
View |
| 2007-01-03 Option Award | 2007-01-05 2:41 pm | N/A 2017-01-03 | BIOENVISION INC | BIVN | LUCI DAVID P (EVP & Gen. Counsel) | 140,000 | $4.6 | 585,000 (Direct) | View |
| 2007-01-03 Option Award |
2007-01-05 2:40 pm |
N/A 2017-01-03 |
BIOENVISION INC | BIVN | Kauffman Michael (Director) | 25,000 | $4.6 | 72,500 (Direct) | View |
| 2007-01-03 Option Award |
2007-01-05 2:38 pm |
N/A 2017-01-03 |
BIOENVISION INC | BIVN | Dunker Kristen Marie (See Exhibit 99.1) | 57,500 | $4.6 | 301,250 (Direct) |
View |
| 2007-01-03 Option Award |
2007-01-05 2:36 pm | N/A 2017-01-03 | BIOENVISION INC | BIVN | Cooper Joseph Patrick (Director) | 6,250 | $4.6 | 31,250 (Direct) |
View |
| 2006-11-01 Exercise | 2006-11-03 4:20 pm | N/A 2006-11-16 |
BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 1,200,000 | $1.25 | 0 (Direct) |
View |
| 2006-11-01 Exercise |
2006-11-03 4:20 pm | N/A 2006-11-16 | BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 150,000 | $1.25 | 0 (Indirect) |
View |
| 2006-11-01 Exercise |
2006-11-03 4:20 pm |
N/A 2006-11-16 |
BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 150,000 | $1.25 | 0 (Indirect) | View |
| 2006-11-01 Exercise |
2006-11-03 4:20 pm | N/A 2006-11-16 | BIOENVISION INC | BIVN | SCO CAPITAL PARTNERS LLC Rouhandeh Steven H (10% owner) | 90,000 | $1.25 | 0 (Indirect) | View |
| 2006-04-03 Exercise |
2006-04-05 4:33 pm | 2006-03-31 2013-03-31 | BIOENVISION INC | BIVN | LUCI DAVID P (CFO & Gen. Counsel) | 110,000 | $0.735 | 445,000 (Direct) | View |
| 2006-02-27 Exercise |
2006-03-01 2:05 pm |
2005-10-23 2012-10-23 |
BIOENVISION INC | BIVN | Griffith Hugh (Chief Operating Officer) | 125,000 | $1.45 | 760,000 (Direct) | View |
| 2006-02-27 Exercise | 2006-03-01 2:03 pm | 2005-01-06 2013-01-06 |
BIOENVISION INC | BIVN | Abercrombie Ian (Sales Manager (Europe)) | 50,000 | $1.29 | 136,250 (Direct) | View |
| 2004-12-13 Purchase |
2004-12-16 09:54 am |
N/A N/A | BIOENVISION INC | BIVN | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP (10% owner) | 750,000 | $0 | 2,250,000 (Direct) | View |
| 2004-05-13 Purchase | 2004-05-17 5:41 pm |
2004-05-13 2009-05-13 | BIOENVISION INC | BIV | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC PERSEUS BIOTECH FUND PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC PEARL FRANK H SOROS GEORGE SOROS FUND MANAGEMENT LLC PERSEUS EC LLC PERSEUSPUR LLC (10% owner) | 75,009 | $7.5 | 75,009 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 07 Nov 2009 22:17:22 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |